Association of congenital cardiac defects and the C677T methylenetetrahydrofolate reductase polymorphism

Prenatal Diagnosis

Volumn 27, Issue 8, 2007, Pages 704-708

  Wintner, Sonja ^a   Hafner, Erich ^a   Stonek, Felix ^a   Stuempflen, Ingrid ^a   Metzenbauer, Martin ^a   Philipp, Karl ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Aortic arch; Congenital heart disease; Homocysteine; Malformation; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AORTA ARCH ANOMALY; ARTICLE; CASE CONTROL STUDY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA HYBRIDIZATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; NEURAL TUBE DEFECT; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AORTIC ARCH SYNDROMES; AUSTRIA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 34547807717     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1761     Document Type: Article

References (32)

1. Botto LD, Yang Q. 2000. 5,10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: a huge review. Am J Epidemiol 151: 862-877.
2. Botto LD, Khoury MJ, Mulinare J, Erickson JD. 1996. Periconceptional multivitamin use and the occurence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 98: 911-917.
3. Creazzo TI, Godt RE, Leatherbury L, Conway SJ, Kirby ML. 1998. Role of cardiac neural crest cells in cardiovascular developement. Annu Rev Physiol 60: 267-286.
4. Czeizel AE. 1996. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62(2): 179-183.
5. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835.
6. Frosst SE, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1): 111-113.
7. Guo Z, Guilfoyle RA, Thiel AJ, Wang R, Smith LM. 1994. Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res 22(24): 5456-5465.
8. Hofmann JIE, Christianson R. 1978. Congenital heart disease in a cohort of 19,502 births with long-term follow up. Am J Cardiol 42: 641-647.
9. Huber M, Mundlein A, Dornstauder E, Schneeberger C, Tempfer CB, Mueller MW. 2002. Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays. Anal Biochem 303(1): 25-33.
10. Jacques PF, Bostom AG, Williams RR, et al. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation 93: 7-9.
11. Junker R, Kotthoff S, Vielhaber H, et al. 2001. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 51(2): 251-254.
12. Kapusta L, Haagmans MLM, Steegers EAP, Cuypers MHM, Blom HJ, Eskes TKAB. 1999. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135: 773-774.
13. Kirby ML, Waldo KL. 1990. Role of neural crest in congenital heart disease. Circulation 82(2): 332-340.
14. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157: 487-492.
15. Limpach A, Dalton M, Miles R, Gadson P. 2000. Homocysteine inhibits retinoic acid synthesis: a mechanism for homocysteine-induced congenital defects. Exp Cell Res 260(1): 166-174.
16. McBride KL, Fernbach S, Menesses A, et al. 2004. A family-based association study of congenital left-sided heart malformations and 5,10 methylenetetrahydrofolate reductase. Birth Defects Res A Clin Mol Teratol 70(10): 825-830.
17. Mitchell SC, Korones SB, Berendes HW. 1971. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 43: 323-332.
18. Molloy AM, Mills JL, Kirke PN, et al. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylene- tetrahydrofolate reductase: low folate alone may be the critical factor. Am J Med Genet 78(2): 155-159.
19. Nelen WL. 2001. Hyperhomcysteinaemia and human reproduction. Clin Chem Lab Med 39(8): 758-763.
20. Pease AC, Solas D, Sullivan EJ, Cronin MT, Holmes CP, Fodor SP. 1994. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci USA 91(11): 5022-5026.
21. Pereira AC, Xavier-Neto J, Mesquita SM, Mota GFA, Lopes AA, Krieger JE. 2005. Lack of evidence of association between MTHFR C677T polymorphism and congenital heart disease in a TDT study design. Int J Cardiol 105: 15-18.
22. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. 1995. Maternal periconceptional use of of multivitamins and reduced risk for conotruncal heart defects and limb deficiences among offspring. Am J Med Genet 59: 536-545.
23. Shaw GM, Iovannisci DM, Yang W, et al. 2005. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet 138A: 21-26.
24. Shields DC, Kirke PN, Mills JL, et al. 1999. The 'thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and relative importance of genotypes of embryo and the mother. Am J Hum Genet 64: 1045-1055.
25. Southern E, Mir K, Shchepinov M. 1999. Molecular interactions on microarrays (review). Nat Genet 21(Suppl.1): 5-9.
26. Stanger O (ed). 2004. Homocystein: Grundlagen, Klinik, Therapie, Prävention. Wilhelm Maudrich: Wien-München-Bern.
27. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. 1991. Neural-tube defects and derangement of homcysteine metabolism. N Engl J Med 324: 199-200.
28. Steegers-Theunissen RP, Boers GH, Trijbels FJ, et al. 1994. Maternal hyperhomocysteinaemia: a risk factor for neural-tube defects? Metabolism 43(12): 1475-1480.
29. Storti S, Vittorini S, Iascone MR, et al. 2003. Association between 5,10-methylene-tetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab Med 41(3): 276-280.
30. Van der Put NM, Steegers-Theunissen RP, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1071.
31. Vollset SE, Refsum H, Irgens LM, et al. 2000. Plasma total homocystein, pregnancy complications, and adverse pregnancy outcomes: the hordaland homocysteine study. Am J Clin Nutr 71: 962-968.
32. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. 2001. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 184: 806-817.